loading

Who We Are

Oviya MedSafe is a global Pharmacovigilance Consulting & Drug Safety Services company incorporated in India in 2012 and in the United Kingdom in 2014, offering advisory and outsourced support to the pharmaceutical industry. Oviya MedSafe is backed by 50 years of collective intelligence of its founding groups and works with renowned pharmaceutical companies and marketing authorization holders in various parts of the world.

Oviya MedSafe provides end-to-end global drug safety support (combined with regulatory-compliant drug safety database access, as required) to pharmaceutical companies with mature pharmacovigilance systems. More importantly, Oviya MedSafe comprehensively consults to generic pharmaceutical companies across the globe to help them constantly evolve their pharmacovigilance departments to be in line with the regulations pertinent to their market presence.

Read More

Our Services

PHARMACOVIGILANCE CONSULTING

Oviya MedSafe offers comprehensive global pharmacovigilance consulting solutions through regulatory compliance, higher productivity and strategic drug safety outcomes. Oviya MedSafe has the broad-based experience in pharmacovigilance domain to help you address product safety concerns in a confident, proactive manner, and operating experience to provide unparalleled support to our clients.

Read More

DRUG SAFETY SERVICES

With in-depth expertise of safety reporting in clinical studies and post-marketing surveillance, Oviya MedSafe provide comprehensive global drug safety services.From individual customized stand-alone services to diverse offerings, Oviya MedSafe provides solutions specific to the requirements of our clients.

Read More

News & Events

  • 28

    Feb

    Oviya MedSafe – DRUG DILIGENCE 2017 and Honours from DIA & ISPOR

    February 2017 edition of our newsletter

    Continue Reading...
  • 27

    Feb

    Drug Diligence 2017 – 17th & 18th March – Coimbatore

    Press Release from VHEO Ventures

    Continue Reading...
  • 31

    Jan

    Oviya MedSafe – Building Pharmacovigilance Strategies & Invited Article in DIA Global Forum

    January 2017 edition of our newsletter

    Continue Reading...
  • 31

    Dec

    Oviya MedSafe fosters Industry-Academia Partnerships for Pharmacovigilance

    December 2016 edition of our newsletter

    Continue Reading...
  • 30

    Nov

    Oviya MedSafe – Pragmatic Pharmacovigilance Support for US ANDA Holders

    November 2016 edition of our newsletter

    Continue Reading...
  • 31

    Oct

    Oviya MedSafe – India Pharmacovigilance Support for Local Affiliates of Global Pharma

    October 2016 edition of our newsletter

    Continue Reading...
  • 30

    Sep

    Oviya MedSafe – Viewing Pharmacovigilance as a Value Addition for the Pharmaceutical Industry

    September 2016 edition of our newsletter

    Continue Reading...
  • 31

    Aug

    Oviya MedSafe in Outsourced Pharmacovigilance – Comprehensivising the Compartmentalised

    August 2016 edition of our newsletter

    Continue Reading...
  • 31

    Jul

    Oviya MedSafe – Redefining Leadership in Pharmacovigilance

    July 2016 edition of our newsletter

    Continue Reading...
  • 30

    Jun

    Oviya MedSafe – Brexit, EU Clientele & Indian Pharmacovigilance

    June 2016 edition of our newsletter

    Continue Reading...
View All